{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:43:05Z","timestamp":1775108585625,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016239","name":"University of Occupational and Environmental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016239","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K12146"],"award-info":[{"award-number":["24K12146"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K07303"],"award-info":[{"award-number":["20K07303"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jphs.2026.01.004","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:28:21Z","timestamp":1768580901000},"page":"176-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Postoperative administration of 2,5-dimethylcelecoxib attenuates ischemia-reperfusion injury-induced cardiac dysfunction"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1743-7730","authenticated-orcid":false,"given":"Shin","family":"Ishikane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Kishigami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eigo","family":"Ikushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Arioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunobu","family":"Igawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumi","family":"Takahashi-Yanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jphs.2026.01.004_bib1","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1097\/JS9.0000000000001975","article-title":"Protective effect of sevoflurane on myocardial ischemia-reperfusion injury: a systematic review and meta-analysis","volume":"110","author":"Nasiri-Valikboni","year":"2024","journal-title":"Int J Surg"},{"issue":"4","key":"10.1016\/j.jphs.2026.01.004_bib2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/FJC.0000000000000980","article-title":"Pharmacologic prevention of myocardial ischemia-reperfusion injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"77","author":"Kakavand","year":"2021","journal-title":"J Cardiovasc Pharmacol"},{"issue":"19","key":"10.1016\/j.jphs.2026.01.004_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197165","article-title":"Innate immunity effector cells as inflammatory drivers of cardiac fibrosis","volume":"21","author":"Baci","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jphs.2026.01.004_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","article-title":"Myocardial ischemia-reperfusion injury and the influence of inflammation","volume":"33","author":"Algoet","year":"2023","journal-title":"Trends Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.jphs.2026.01.004_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165768","article-title":"Mitochondrial ROS in myocardial ischemia reperfusion and remodeling","volume":"1866","author":"Bugger","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.jphs.2026.01.004_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/01.CIR.88.1.107","article-title":"Survival after the onset of congestive heart failure in framingham heart Study subjects","volume":"88","author":"Ho","year":"1993","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jphs.2026.01.004_bib7","doi-asserted-by":"crossref","first-page":"H2557","DOI":"10.1152\/ajpheart.00858.2007","article-title":"The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats","volume":"293","author":"Sato","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"10.1016\/j.jphs.2026.01.004_bib8","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/sj.bjp.0704585","article-title":"Inhibition of cyclo-oxygenase-2 exacerbates ischaemia-induced acute myocardial dysfunction in the rabbit","volume":"135","author":"Rossoni","year":"2002","journal-title":"Br J Pharmacol"},{"issue":"971","key":"10.1016\/j.jphs.2026.01.004_bib9","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/pgmj.2005.043711","article-title":"Cyclooxygenase-2 plays an essential part in cardioprotection of delayed phase of recombinant human erythropoietin preconditioning in rats","volume":"82","author":"Liu","year":"2006","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1016\/j.jphs.2026.01.004_bib10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/FJC.0b013e3181aa3905","article-title":"Chronic pretreatment with celecoxib reduces infarct size","volume":"54","author":"Lada-Moldovan","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jphs.2026.01.004_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2019.109485","article-title":"Cyclooxygenase inhibition prior to ventricular fibrillation induced ischemia reperfusion injury impairs survival and outcomes","volume":"135","author":"Adams","year":"2020","journal-title":"Med Hypotheses"},{"issue":"6087","key":"10.1016\/j.jphs.2026.01.004_bib12","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1126\/science.1224398","article-title":"Physiology. COX-2 inhibitors and cardiovascular risk","volume":"336","author":"Cannon","year":"2012","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.jphs.2026.01.004_bib13","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s10495-007-0122-4","article-title":"Celecoxib after the onset of reperfusion reduces apoptosis in the amygdala","volume":"12","author":"Kaloustian","year":"2007","journal-title":"Apoptosis"},{"issue":"5","key":"10.1016\/j.jphs.2026.01.004_bib14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jacc.2020.06.017","article-title":"Cardiovascular and bleeding risks associated with nonsteroidal anti-inflammatory drugs after myocardial infarction","volume":"76","author":"Kang","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jphs.2026.01.004_bib15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bcp.2019.06.018","article-title":"2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation","volume":"168","author":"Morishige","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jphs.2026.01.004_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114950","article-title":"2,5-Dimethylcelecoxib attenuates cardiac fibrosis caused by cryoinjury-induced myocardial infarction by suppressing the fibroblast-to-myofibroblast transformation via inhibition of the TGF-\u03b2 signaling pathway","volume":"197","author":"Ikushima","year":"2022","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.jphs.2026.01.004_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jphs.2024.01.001","article-title":"2,5-Dimethyl-celecoxib induces early termination of inflammatory responses by transient macrophage accumulation and inhibits the progression of cardiac remodeling in a mouse model of cryoinjury-induced myocardial infarction","volume":"154","author":"Kishigami","year":"2024","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.jphs.2026.01.004_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/hr.2016.122","article-title":"2,5-Dimethylcelecoxib prevents pressure-induced left ventricular remodeling through GSK-3 activation","volume":"40","author":"Fujita","year":"2017","journal-title":"Hypertens Res"},{"issue":"8","key":"10.1016\/j.jphs.2026.01.004_bib19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/TP.0b013e31829f753d","article-title":"Allogeneic transplantation of fetal membrane-derived mesenchymal stem cell sheets increases neovascularization and improves cardiac function after myocardial infarction in rats","volume":"96","author":"Ishikane","year":"2013","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.jphs.2026.01.004_bib20","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1634\/stemcells.2008-0236","article-title":"Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia","volume":"26","author":"Ishikane","year":"2008","journal-title":"Stem Cell"},{"issue":"1 Pt 1","key":"10.1016\/j.jphs.2026.01.004_bib21","first-page":"G134","article-title":"An in vitro model of ischemia\/reperfusion-induced microvascular injury","volume":"259","author":"Inauen","year":"1990","journal-title":"Am J Physiol"},{"issue":"11","key":"10.1016\/j.jphs.2026.01.004_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.31083\/j.rcm2511419","article-title":"The role of cardiac macrophages in inflammation and fibrosis after myocardial ischemia-reperfusion","volume":"25","author":"Jin","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jphs.2026.01.004_bib23","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.2147\/JIR.S436560","article-title":"Macrophage heterogeneity and its impact on myocardial ischemia-reperfusion injury: an integrative review","volume":"16","author":"Xu","year":"2023","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jphs.2026.01.004_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2024.02.007","article-title":"Recent advances in potential targets for myocardial ischemia reperfusion injury: role of macrophages","volume":"169","author":"Zhuang","year":"2024","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jphs.2026.01.004_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115663","article-title":"Promising small molecule anti-fibrotic agents: newly developed or repositioned drugs targeting myofibroblast transdifferentiation","volume":"214","author":"Ishikane","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.jphs.2026.01.004_bib26","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/bph.15068","article-title":"The role of mitochondrial dynamics in cardiovascular diseases","volume":"178","author":"Forte","year":"2021","journal-title":"Br J Pharmacol"},{"issue":"17","key":"10.1016\/j.jphs.2026.01.004_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.180906","article-title":"Enhancing mitochondrial pyruvate metabolism ameliorates ischemic reperfusion injury in the heart","volume":"9","author":"Visker","year":"2024","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.jphs.2026.01.004_bib28","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/cvr\/cvae116","article-title":"Cardiomyocyte \u03b2II spectrin plays a critical role in maintaining cardiac function by regulating mitochondrial respiratory function","volume":"120","author":"Yang","year":"2024","journal-title":"Cardiovasc Res"},{"issue":"1-2","key":"10.1016\/j.jphs.2026.01.004_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11010-016-2849-0","article-title":"Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research","volume":"424","author":"Rai","year":"2017","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"10.1016\/j.jphs.2026.01.004_bib30","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.116.303790","article-title":"Molecular mechanisms of mitochondrial autophagy\/mitophagy in the heart","volume":"116","author":"Saito","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jphs.2026.01.004_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-physiol-021317-121427","article-title":"The role of autophagy in the heart","volume":"80","author":"Sciarretta","year":"2018","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jphs.2026.01.004_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.905072","article-title":"Current understanding of the pivotal role of mitochondrial dynamics in cardiovascular diseases and senescence","volume":"9","author":"Uchikado","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.jphs.2026.01.004_bib33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1113\/JP271301","article-title":"Mitochondrial dynamics, mitophagy and cardiovascular disease","volume":"594","author":"V\u00e1squez-Trincado","year":"2016","journal-title":"J Physiol"},{"issue":"2","key":"10.1016\/j.jphs.2026.01.004_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10741-016-9530-2","article-title":"Mitochondrial dynamics and cell death in heart failure","volume":"21","author":"Mar\u00edn-Garc\u00eda","year":"2016","journal-title":"Heart Fail Rev"},{"issue":"3","key":"10.1016\/j.jphs.2026.01.004_bib35","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease","volume":"117","author":"Berk","year":"2007","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jphs.2026.01.004_bib36","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41420-020-00316-9","article-title":"Mitochondrial dysfunction in fibrotic diseases","volume":"6","author":"Li","year":"2020","journal-title":"Cell Death Discov"},{"issue":"4","key":"10.1016\/j.jphs.2026.01.004_bib37","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.4049\/jimmunol.1000017","article-title":"Proinflammatory clearance of apoptotic neutrophils induces an IL-12(low)IL-10(high) regulatory phenotype in macrophages","volume":"185","author":"Filardy","year":"2010","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jphs.2026.01.004_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cmet.2018.12.004","article-title":"Efferocytosis fuels requirements of Fatty acid oxidation and the electron transport chain to polarize macrophages for tissue repair","volume":"29","author":"Zhang","year":"2019","journal-title":"Cell Metab"},{"issue":"7","key":"10.1016\/j.jphs.2026.01.004_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071716","article-title":"Cardiac Fibrosis and fibroblasts","volume":"10","author":"Kurose","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.jphs.2026.01.004_bib40","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI74783","article-title":"Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis","volume":"124","author":"Moore-Morris","year":"2014","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.jphs.2026.01.004_bib41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bcp.2008.04.008","article-title":"Dimethylcelecoxib inhibits prostaglandin E2 production","volume":"76","author":"Wobst","year":"2008","journal-title":"Biochem Pharmacol"},{"issue":"15","key":"10.1016\/j.jphs.2026.01.004_bib42","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/bph.16061","article-title":"Microsomal prostaglandin E synthase-1 inhibition prevents adverse cardiac remodelling after myocardial infarction in mice","volume":"180","author":"Zhang","year":"2023","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861326000046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861326000046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T04:17:38Z","timestamp":1775103458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861326000046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1347861326000046"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2026.01.004","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postoperative administration of 2,5-dimethylcelecoxib attenuates ischemia-reperfusion injury-induced cardiac dysfunction","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2026.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}